Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Journos chronicle disregard for privacy, intimidation of whistleblowers at the VA

From long waits to manipulated medical records to preventable deaths, the Department of Veterans Affairs has had more than its share of problems over the past few years. That’s no secret. 

Thumbnail

Pediatric hospitals hit hard by ACA payment reductions

Anticipating a plunge in the number of uninsured patients, the framers of the Affordable Care Act reduced disproportionate-share (DSH) payments to hospitals serving outsized indigent and Medicaid populations. A recent crunch of the numbers shows the cuts are placing particular pains on children’s hospitals. 

Thumbnail

FTC plans on blocking proposed merger between two Chicago hospitals

The Federal Trade Commission (FTC) announced on Dec. 18 that it planned on blocking the proposed merger of two major hospital systems in Chicago, the third time in six weeks that the FTC challenged a proposed hospital merger.

Why aren't patients taking advantage of zero cost colonoscopies?

By cutting patients’ out-of-pocket expenses for screening mammography, the Affordable Care Act succeeded in sending many more women for the exams. Now comes a review of Medicare claims revealing that the effect was nowhere to be found in the target population for screening colonoscopy.

$1.1T spending bill suspends device and insurance taxes

The House of Representatives released specifics on a $1.1 trillion funding bill that includes a package of tax breaks, coming down to the wire on Tuesday, Dec. 15, to finalize the bill by the deadline.

CHIME to CMS: Hold off on Stage 3

The College of Healthcare Information Management Executives (CHIME) is urging the federal government to give healthcare providers more time to adjust to recent changes to the Meaningful Use program before mandating new and burdensome Stage 3 requirements.

Thumbnail

AEI panel examines medical malpractice

The American Enterprise Institute (AEI) held a panel discussion earlier this month, discussing medical malpractice reform along with a variety of other topics. 

Thumbnail

Year in Review: ICD-10 finally happens

Maybe you’re familiar with a little effort called ICD-10 that has been the subject of delays, debate, regulations, contingencies and more for several years now.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.